tiprankstipranks
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market

Kiniksa Pharmaceuticals (KNSA) Income Statement

Compare
448 Followers

Kiniksa Pharmaceuticals Income Statement

Last quarter (Q4 2024), Kiniksa Pharmaceuticals's total revenue was $122.54M, an increase of 46.93% from the same quarter last year. In Q4, Kiniksa Pharmaceuticals's net income was $-8.89M. See Kiniksa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 423.24M$ 270.26M$ 220.18M$ 38.54M$ 0.00
Gross Profit
$ 423.24M$ 213.74M$ 173.21M$ 29.44M$ -3.81M
Operating Expenses
$ 468.86M$ 238.93M$ 163.44M$ 186.08M$ 157.36M
Depreciation and Amortization
$ 0.00$ 2.34M$ 4.22M$ 4.09M$ 3.81M
EBITDA
$ -45.62M$ -22.86M$ 9.77M$ -154.28M$ -152.42M
Operating Income
$ -45.62M$ -25.20M$ 7.37M$ -156.64M$ -157.36M
Other Income/Expenses
$ 9.46M$ 8.54M$ 1.25M$ 97.00K$ 1.13M
Pretax Income
$ -36.15M$ -16.65M$ 11.03M$ -156.54M$ -156.23M
Net Income
$ -43.19M$ 14.08M$ 183.36M$ -157.92M$ -161.38M
Per Share Metrics
Basic EPS
$ -0.60$ 0.20$ 2.64$ -2.30$ -2.61
Diluted EPS
$ -0.60$ 0.20$ 2.60$ -2.30$ -2.61
Weighted Average Shares Outstanding
71.42M 70.06M 69.38M 68.58M 61.84M
Weighted Average Shares Outstanding (Diluted)
71.42M 71.92M 70.42M 68.58M 61.84M
Currency in USD

Kiniksa Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis